Bioequivalence Study of BGM0504 Injection

NCT07382908 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight/Obesity

Interventions

DRUG: BGM0504 Injection multi-dose pen
DRUG: BGM0504 Injection single-dose pen
DRUG: BGM0504 Injection single-dose pen

Sponsor

BrightGene Bio-Medical Technology Co., Ltd.

Collaborators

[object Object]